MatOrtho is a UK-based designer and manufacturer of pioneering orthopaedic devices.
In June 2021, Connection Capital clients invested in a £6.75m private equity transaction to support its international growth and product development.
The Company
Founded in 2010, MatOrtho designs, manufactures and commercialises performance leading, orthopaedic implant devices. It is one of the UK’s most innovative orthopaedic device designers. The company has achieved strong growth and has built a truly global presence, supplying implant devices into many of the world’s orthopaedic markets.
MatOrtho’s mission is improving the quality of life of all patients who receive one of its devices. Based in Leatherhead, the company has an international reputation for technical innovation. Its range of advanced knee, hip, and finger replacement procedures consistently deliver clinically proven, best-in-class patient outcomes for implant performance and sustained use with better patient satisfaction.
Investment Rationale
The private equity investment will enable MatOrtho to accelerate international expansion into new and existing markets and will support research and development as the company continues to develop the next generation of implant technology. The management team will be supported by experienced industry figure, Simon Cartmell, previously CEO of ApaTech, who has joined the board as a Non-Executive.
MatOrtho Deal Team
View full SME investment teamYou might also be interested in
Private Equity
Cargostore
Secondary MBO of specialist container provider with global footprint.
Discover morePrivate Equity
Tempcover
Exit from insurtech generated a return materially in excess of 5x.
Discover morePrivate Equity
23.5 Degrees
Growth capital support for the world's first Starbuck's franchisee.
Discover morePrivate Equity
Virgin Wines
MBO support for Virgin Wines. The exit, via IPO, generated 7.7x return on investment.
Discover more